Clinical Trials Arena on MSNOpinion
What happens when protocol data finally flows
Rob DiCicco, vice president of portfolio management, and Bill Illis, workstream leader, digital data flow at TransCelerate ...
Despite impressive innovations in medicine, most advanced-stage cancers still carry a grim prognosis. Developing more ...
Researchers at the University of Würzburg have unveiled a new tool for analysing RNA molecules. It visualises their ...
Introduction Congenital malformations (CMs) are the leading cause of infant mortality. Still, the aetiology remains unknown in 70% of cases. The most accepted hypothesis is that hereditary and ...
Experts at a MediaNama roundtable discussed the harms and benefits of social media for children, including cyberbullying, ...
The next WHO director general inherits a fractured geopolitical landscape in which multilateral norms cannot be taken for ...
Ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor, reduced symptomatic RT-PCR-confirmed COVID-19 among household ...
Introduction Serum chloride has been recently recognised as a predictor of short-term mortality in patients hospitalised with ...
Climate change is driving the emergence and re-emergence of climate-sensitive infectious diseases in Canada. Such emerging ...
Gestational age at onset: the vast majority of patients had a gestational age equal to or less than 32 weeks (39.77%) against 34.66% who were between 33 and 36 weeks and more than 37 weeks for 25.57% ...
A planned first-in-human trial aims to treat GM1 gangliosidosis in utero, possibly laying the foundation for prenatal gene ...
Rheumatoid arthritis (RA) susceptibility is strongly influenced by genetic variations within the major histocompatibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results